A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elvitegravir Impurity 15 - Request Quote

Picture of Elvitegravir Impurity 15

Elvitegravir Impurity 15

SZ CAT No:SZ-E078033
CAS No
NA
Mol.F.
C19H18ClFO3
Mol.Wt.
348.8
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Elvitegravir Impurity 15 is chemically Ethyl 3-(3-(3-chloro-2-fluorobenzyl)-4-methylphenyl)-3-oxopropanoate. Elvitegravir Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Elvitegravir Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Elvitegravir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Elvitegravir Impurity 15

Purchase Elvitegravir Impurity 15

Elvitegravir Impurity 15 suppliers

Elvitegravir Impurity 15 manufacturers

Elvitegravir Impurity 15 price

Order Elvitegravir Impurity 15

Enquire Elvitegravir Impurity 15

Elvitegravir Impurity 15 cost

Elvitegravir Impurity 15 Supplier

Elvitegravir Impurity 15 Distributor

Elvitegravir Impurity 15 for Method Validation

Elvitegravir Reference Standard

Elvitegravir Impurity 15 for ANDA Filing

Elvitegravir Impurity 15 for Forced Degradation Studies

Elvitegravir Impurity 15 Identification Standards

Elvitegravir Impurity 15 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,